RCT: Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia.
19 Jan, 2022 | 08:11h | UTCSafety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study – The Lancet Neurology (link to abstract – $ for full-text)